Cite
HARVARD Citation
Woods, J. et al. (2022). Phase Ib trial of lenalidomide as post-remission therapy for older adults with acute myeloid leukemia: Safety and longitudinal assessment of geriatric functional domains. Journal of geriatric oncology. 13 (4), pp. 499-504. [Online].